Suppr超能文献

工艺变量对不可降解微粒的粉体学性质及药物释放的影响

Effects of process variables on micromeritic properties and drug release of non-degradable microparticles.

作者信息

Jelvehgari Mitra, Barar Jaleh, Nokhodchi Ali, Shadrou Sanam, Valizadeh Hadi

机构信息

Faculty of Pharmacy, Tabriz University of Medical Sciences, Iran. ; Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2011;1(1):18-26. doi: 10.5681/apb.2011.003. Epub 2011 Jul 30.

Abstract

INTRODUCTION

The purpose of this investigation was to evaluate microencapsulated controlled release preparation of theophylline using Eudragit RS 100 as the retardant material with high entrapment efficiency.

METHODS

Microspheres were prepared by the emulsion-solvent evaporation method. A mixed solvent system consisting of methanol and acetone and light liquid paraffin as oily phase were chosen. Sucrose stearate was used as the surfactant to stabilize the emulsification process. The prepared microspheres were characterized by drug loading, Fourier-transform infrared spectroscopy (FTIR), differential scanning colorimetry (DSC) and scanning electron microscopy (SEM). The in vitro release studies were performed at pH 1.2 and 7.4 aqueous medium.

RESULTS

Increasing the concentration of emulsifier, sucrose fatty acid ester F-70, decreased the particle size which contributed to increased drug release rate. The drug loading microparticle Eudragit RS100(1:6) showed 60-75% of entrapment and mean particle size 205.93-352.76 μm.The results showed that, an increase in the ratio of polymer: drug (F5, 6: 1) resulted in a reduction in the release rate of the drug which may be attributed to the hydrophobic nature of the polymer.

CONCLUSION

The release of theophylline is influenced by the drug to polymer ratio and particle size. Drug release is controlled by diffusion and the best-fit release kinetic is Higuchi model.

摘要

引言

本研究的目的是评估以Eudragit RS 100为阻滞剂材料、包封率高的茶碱微囊控释制剂。

方法

采用乳液-溶剂蒸发法制备微球。选择由甲醇和丙酮组成的混合溶剂体系以及轻质液状石蜡作为油相。使用蔗糖硬脂酸酯作为表面活性剂来稳定乳化过程。通过载药量、傅里叶变换红外光谱(FTIR)、差示扫描量热法(DSC)和扫描电子显微镜(SEM)对制备的微球进行表征。在pH 1.2和7.4的水性介质中进行体外释放研究。

结果

增加乳化剂蔗糖脂肪酸酯F-70的浓度会降低粒径,这有助于提高药物释放速率。载药微粒Eudragit RS100(1:6)的包封率为60 - 75%,平均粒径为205.93 - 352.76μm。结果表明,聚合物与药物比例(F5,6:1)的增加导致药物释放速率降低,这可能归因于聚合物的疏水性。

结论

茶碱的释放受药物与聚合物比例及粒径的影响。药物释放受扩散控制,最佳拟合释放动力学为Higuchi模型。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验